market

Novo Nordisk slashes U.S. drug prices up to 50% by 2027 and partners with OpenAI to counter Eli…

Novo Nordisk partners with OpenAI for drug discovery but faces a fierce price war in key Asian markets…

Novo Nordisk slashes US Wegovy HD price to $399/month, partners with OpenAI for AI integration, and faces generic…

Novo Nordisk’s share price hits 12-month low despite a major buyback and launch of Wegovy HD & oral…

Novo Nordisk launches a major share buyback despite its first revenue drop in 25 years, balancing challenges with…

Novo Nordisk counters revenue decline and Eli Lilly’s market lead with a Wegovy subscription model, aiming to lock…

Novo Nordisk’s semaglutide patent expires in India, sparking generic price war. Stock hits 52-week low while trading ex-dividend,…

Everyone’s talking about A.P. Møller – Mærsk A/S, but is this global shipping beast actually worth your money…

WindEurope welcomes the announcement by Vestas to build a nacelle factory near Szczecin in Poland for offshore wind…

Novo Nordisk receives FDA warning over safety reporting delays but secures a new sales channel for Ozempic and…

FDA warns 30 firms over compounded semaglutide claims and reprimands Novo Nordisk for Ozempic ad. The dual action…

Wednesday, 4 March 2026, 12:24 The representatives of Andalucía, the Costa del Sol and Malaga city at the…

Novo Nordisk’s Price War and AI Gamble to Defend Market Crown